A comparison of volume-reduced versus standard HLA/HPA-matched apheresis platelets in alloimmunized adult patients

Transfusion

Volumn 52, Issue 4, 2012, Pages 742-751

  Honohan, Áine ^a,b   Tomson, Bert ^a,b   Van Der Bom, Johanna ^a,b   De Vries, René ^a,b   Brand, Anneke ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; HLA ANTIBODY; THROMBOCYTE ANTIGEN;

ADOLESCENT; ADULT; ADVERSE OUTCOME; ALLOIMMUNIZATION; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD TRANSFUSION REACTION; CHILL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DYSPNEA; ERYTHEMA; FEMALE; GLOTTIS EDEMA; HLA SYSTEM; HUMAN; HYPOTENSION; LARYNX EDEMA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRURITUS; TACHYCARDIA; THROMBOCYTE TRANSFUSION; THROMBOCYTOPHERESIS; URINE COLOR; URTICARIA; VOLUME REDUCED THROMBOCYTOPHERESIS; VOMITING;

ADULT; AGED; ANTIGENS, HUMAN PLATELET; COHORT STUDIES; FEMALE; HISTOCOMPATIBILITY TESTING; HUMANS; ISOANTIBODIES; MALE; MIDDLE AGED; PLATELET TRANSFUSION; PLATELETPHERESIS; TIME FACTORS;

EID: 84859745349     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03364.x     Document Type: Article

References (31)

1. Schoenfeld H, Spies C, Jakob C,. Volume-reduced platelet concentrates. Curr Hematol Rep 2006; 5: 82-8.
2. Holme S, Heaton WA, Moroff G,. Evaluation of platelet concentrates stored for 5 days with reduced plasma volume. Transfusion 1994; 34: 39-43.
3. Moroff G, Friedman A, Robkin-Kline L, Gautier G, Luban NL,. Reduction of the volume of stored platelet concentrates for use in neonatal patients. Transfusion 1984; 24: 144-6.
4. Pisciotto PT, Snyder EL, Snyder JA, Frattaroli S, Hopfer SM, Rinder HM, Smith BR,. In vitro characteristics of white cell-reduced single-unit platelet concentrates stored in syringes. Transfusion 1994; 34: 407-11.
5. Rock G, Haddad SA, Poon AO, Romans RA, Sparling CR, St LP, Berger R,. Reduction of plasma volume after storage of platelets in CP2D. Transfusion 1998; 38: 242-6.
6. Zilber M, Friedman Z, Shapiro H, Shapira S, Radnay J, Ellis MH,. The effect of plasma depletion of platelet concentrates on platelet aggregation and phosphatidylserine expression. Clin Appl Thromb Hemost 2003; 9: 39-44.
7. Ali AM, Warkentin TE, Bardossy L, Goldsmith CH, Blajchman MA,. Platelet concentrates stored for 5 days in a reduced volume of plasma maintain hemostatic function and viability. Transfusion 1994; 34: 44-7.
8. Allen DL, Samol J, Benjamin S, Verjee S, Tusold A, Murphy MF,. Survey of the use and clinical effectiveness of HPA-1a/5b-negative platelet concentrates in proven or suspected platelet alloimmunization. Transfus Med 2004; 14: 409-17.
9. Dumont LJ, Krailadsiri P, Seghatchian J, Taylor LA, Howell CA, Murphy MF,. Preparation and storage characteristics of white cell-reduced high-concentration platelet concentrates collected by anapheresis system for transfusions in utero. Transfusion 2000; 40: 91-100.
10. Dumont LJ, Beddard R, Whitley P, Johnson A, McNeil D, Sawyer S, Elfath MD,. Autologous transfusion recovery of WBC-reduced high-concentration platelet concentrates. Transfusion 2002; 42: 1333-9.
11. Perseghin P, Mascaretti L, Speranza T, Belotti D, Baldini V, Dassi M, Riva M, Pogliani EM, Sciorelli G,. Platelet activation during plasma-reduced multicomponent PLT collection: a comparison between COBE Trima and Spectra LRS turbo cell separators. Transfusion 2004; 44: 125-30.
12. Rinder HM, Snyder EL, Tracey JB, Dincecco D, Wang C, Baril L, Rinder CS, Smith BR,. Reversibility of severe metabolic stress in stored platelets after in vitro plasma rescue or in vivo transfusion: restoration of secretory function and maintenance of platelet survival. Transfusion 2003; 43: 1230-7.
13. Brand A, van Leeuwen A, Eernisse JG, van Rood JJ,. Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests. Blood 1978; 51: 781-8.
14. de Wildt-Eggen J, Nauta S, Schrijver JG, van Marwijk KM, Bins M, van Prooijen HC,. Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study. Transfusion 2000; 40: 398-403.
15. Kerkhoffs JL, Eikenboom JC, Schipperus MS, van Wordragen-Vlaswinkel RJ, Brand R, Harvey MS, de Vries RR, Barge R, van Rhenen DJ, Brand A,. A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma. Blood 2006; 108: 3210-5.
16. Kerkhoffs JL, van Putten WL, Novotny VM, Te Boekhorst PA, Schipperus MR, Zwaginga JJ, van Pampus LC, de Greef GE, Luten M, Huijgens PC, Brand A,. van Rhenen DJ; Dutch-Belgian HOVON Cooperative Group. Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction. Br J Haematol 2010; 150: 209-17.
17. Tobian AA, Savage WJ, Tisch DJ, Thoman S, King KE, Ness PM,. Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction. Transfusion 2011; 51: 1676-83.
18. Duquesnoy RJ,. HLAMMATCHMAKER: a molecularly based donor selection algorithm for highly alloimmunized patients. Transplant Proc 2001; 33: 493-7.
19. Murphy S, Sayar SN, Gardner FH,. Storage of platelet concentrates at 22°C. Blood 1970; 35: 549-57.
20. O'Connell B, Lee EJ, Schiffer CA,. The value of 10-minute posttransfusion platelet counts. Transfusion 1988; 28: 66-7.
21. Hanson SR, Slichter SJ,. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood 1985; 66: 1105-9.
22. Liang KY, Zeger SL,. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13-22.
23. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med 1997; 337: 1861-9.
24. Kerkhoffs JL, Eikenboom JC, van de Watering LM, van Wordragen-Vlaswinkel RJ, Wijermans PW, Brand A,. The clinical impact of platelet refractoriness: correlation with bleeding and survival. Transfusion 2008; 48: 1959-65.
25. Heim D, Passweg J, Gregor M, Buser A, Theocharides A, Arber C, Meyer-Monard S, Halter J, Tichelli A, Gratwohl A,. Patient and product factors affecting platelet transfusion results. Transfusion 2008; 48: 681-7.
26. Slichter SJ, Davis K, Enright H, Braine H, Gernsheimer T, Kao KJ, Kickler T, Lee E, McFarland J, McCullough J, Rodey G, Schiffer CA, Woodson R,. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 2005; 105: 4106-14.
27. Heddle NM, Klama L, Meyer R, Walker I, Boshkov L, Roberts R, Chambers S, Podlosky L, O'Hoski P, Levine M,. A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets. Transfusion 1999; 39: 231-8.
28. Win N, Chapman CE, Bowles KM, Green A, Bradley S, Edmondson D, Wallis JP,. How much residual plasma may cause TRALI? Transfus Med 2008; 18: 276-80.
29. Silliman CC, Boshkov LK, Mehdizadehkashi Z, Elzi DJ, Dickey WO, Podlosky L, Clarke G, Ambruso DR,. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003; 101: 454-62.
30. Smogorzewska A, Dzik W,. Transfusion medicine illustrated. Volume-reduced apheresis platelets. Transfusion 2005; 45: 651.
31. van der Meer PF, Bontekoe IJ, Kruit G, Peeters G, van Toledo PJ, Tomson B, de Korte D,. Volume-reduced platelet concentrates: optizimation of production and storage conditions. Transfusion 2012; 52: 819-27.